Title : Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation.

Pub. Date : 2020 Mar 26

PMID : 32225074






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation. Tacrolimus cytochrome p450 oxidoreductase Homo sapiens
2 Recently, it has been revealed that the POR*28 polymorphism affects the pharmacokinetics of tacrolimus in renal transplant patients. Tacrolimus cytochrome p450 oxidoreductase Homo sapiens
3 In this study, we examined whether POR*28 as well as CYP3A5*3 polymorphism in Japanese recipients and donors would be another biomarker for the variation of tacrolimus blood levels in the recipients during the first month after living-donor liver transplantation. Tacrolimus cytochrome p450 oxidoreductase Homo sapiens
4 In conclusion, to our knowledge, this is the first report suggesting that the POR*28 polymorphism is another biomarker for the tacrolimus oral dosage after liver transplantation in patients carrying CYP3A5*1 rather than CYP3A5*3/*3. Tacrolimus cytochrome p450 oxidoreductase Homo sapiens